BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14559115)

  • 1. Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bbeta-chain gene.
    Spena S; Asselta R; Duga S; Malcovati M; Peyvandi F; Mannucci PM; Tenchini ML
    Biochim Biophys Acta; 2003 Oct; 1639(2):87-94. PubMed ID: 14559115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene.
    Monaldini L; Asselta R; Duga S; Peyvandi F; Ghosh K; Malcovati M; Tenchini ML
    Haematologica; 2006 May; 91(5):628-33. PubMed ID: 16670068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.
    Duga S; Asselta R; Santagostino E; Zeinali S; Simonic T; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2000 Feb; 95(4):1336-41. PubMed ID: 10666208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
    Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
    Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
    Spena S; Duga S; Asselta R; Malcovati M; Peyvandi F; Tenchini ML
    Blood; 2002 Dec; 100(13):4478-84. PubMed ID: 12393540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
    Asselta R; Duga S; Simonic T; Malcovati M; Santagostino E; Giangrande PL; Mannucci PM; Tenchini ML
    Blood; 2000 Oct; 96(7):2496-500. PubMed ID: 11001902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver histology of an afibrinogenemic patient with the Bbeta-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bbeta-L353R fibrinogen vs. the ERSD-associated gamma-G284R mutant.
    Duga S; Braidotti P; Asselta R; Maggioni M; Santagostino E; Pellegrini C; Coggi G; Malcovati M; Tenchini ML
    J Thromb Haemost; 2005 Apr; 3(4):724-32. PubMed ID: 15842357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the first missense mutation in the fibrinogen Aalpha-chain gene identified in a compound heterozygous afibrinogenemic patient.
    Platé M; Asselta R; Peyvandi F; Tenchini ML; Duga S
    Biochim Biophys Acta; 2007 Jul; 1772(7):781-7. PubMed ID: 17531448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia.
    Asselta R; Duga S; Spena S; Peyvandi F; Castaman G; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2004 Apr; 103(8):3051-4. PubMed ID: 15070683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
    Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
    Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
    Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
    Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
    Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
    Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
    Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
    Castaman G; Rimoldi V; Giacomelli SH; Duga S
    Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs.
    Asselta R; Duga S; Spena S; Santagostino E; Peyvandi F; Piseddu G; Targhetta R; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2001 Dec; 98(13):3685-92. PubMed ID: 11739173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing.
    Margaglione M; Santacroce R; Colaizzo D; Seripa D; Vecchione G; Lupone MR; De Lucia D; Fortina P; Grandone E; Perricone C; Di Minno G
    Blood; 2000 Oct; 96(7):2501-5. PubMed ID: 11001903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.
    Casini A; Lukowski S; Quintard VL; Crutu A; Zak M; Regazzoni S; de Moerloose P; Neerman-Arbez M
    Thromb Res; 2014 May; 133(5):868-74. PubMed ID: 24560896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.